{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:43Z","timestamp":1787071543151,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>The present systematic review and meta analysis was to synthesize the available data, mostly concerning safety and side effects of the available literature on minoxidil therapy for facial hair loss, to provide family physicians with evidence to guide their initial assessment and decisions concerning treatment and referral for this conditions. The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines were followed concerning study selection, synthesis, and reporting. A thorough search was conducted utilizing PubMed, Scopus, Web of Science, and Cochrane databases. A focus was placed on papers published between January 2001 and May 2024. Based on a quality assessment of the study using the standards outlined in the Cochrane Handbook for Systematic Reviews of Interventions, the risk of bias (RoB 2.0) was graded as low, unclear, or high. A total of 302 studies were obtained by our search approach from 294 studies from electronic databases and eight studies from manual search. After duplicates were eliminated, 196 records were left, and 93 studies were eliminated based on their titles and abstracts. An additional 84 studies were eliminated for not meeting inclusion criteria after reading over the complete text of the remaining 103 records. Consequently, the current systematic review contained 19 RCTs. Upon utilizing the RoB 2.0 tool, it became apparent that most of the examined studies raised some concerns about RoB. Five studies reported high RoB, while six studies revealed low RoB. This systematic review establishes low dose minoxidil treatment as an effective intervention for those seeking to enhance facial hair development with relatively minimal side effects, which can be relevant in primary care settings.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_39_25","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:01:03Z","timestamp":1764327663000},"page":"4446-4456","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis"],"prefix":"10.4103","volume":"14","author":[{"given":"Atheer G.","family":"Almutairi","sequence":"first","affiliation":[{"name":"Medical Intern, College of Medicine, Qassim University, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asem","family":"Shadid","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"AlAkrash","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"R1-20251211","first-page":"e14106","article-title":"Safety of low-dose oral minoxidil treatment for hair loss","volume":"33","author":"Jimenez-Cauhe","year":"2020","journal-title":"A systematic review and pooled-analysis of individual patient data. Dermatol Ther"},{"key":"R2-20251211","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders:A review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R4-20251211","first-page":"1","article-title":"Facial hair enhancement with minoxidil \u2014an off-label use","volume":"12","author":"Shokravi","year":"2024","journal-title":"JCMS Case Reports"},{"key":"R5-20251211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40257-022-00729-5","article-title":"Eyebrow and eyelash alopecia:A clinical review","volume":"24","author":"Nguyen","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"R6-20251211","first-page":"e2666","article-title":"Topical treatment of eyebrow hypotrichosis with bimatoprost 0.03% solution:Case Report and Literature Review","volume":"10","author":"Riahi","year":"2018","journal-title":"Cureus"},{"key":"R8-20251211","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/exd.14393","article-title":"Following historical \u201ctracks \u201dof hair follicle miniaturisation in patterned hair loss:Are elastin bodies the forgotten aetiology8239?","volume":"31","author":"Rushton","year":"2022","journal-title":"Exp Dermatol"},{"key":"R9-20251211","doi-asserted-by":"crossref","first-page":"998623","DOI":"10.3389\/fmed.2022.998623","article-title":"Hair regrowth treatment efficacy and resistance in androgenetic alopecia:A systematic review and continuous Bayesian network meta-analysis","volume":"9","author":"Feldman","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R10-20251211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000477671","article-title":"Effectiveness of platelet-rich plasma for androgenetic alopecia:A review of the literature","volume":"4","author":"Cervantes","year":"2018","journal-title":"Ski Appendage Disord"},{"key":"R11-20251211","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jdv.13324","article-title":"Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men:A 104-week open-label clinical trial","volume":"30","author":"Kanti","year":"2016","journal-title":"Eur Acad Dermatol Venereol"},{"key":"R12-20251211","first-page":"e20839","article-title":"Minoxidil, platelet-rich plasma (PRP), or combined minoxidil and PRP for androgenetic alopecia in men:A cost-effectiveness Markov decision analysis of prospective studies","volume":"13","author":"Klifto","year":"2021","journal-title":"Cureus"},{"key":"R13-20251211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/12034754231168839","article-title":"Alopecia areata:An updated review for 2023","volume":"27","author":"Sibbald","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"R14-20251211","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.3390\/jcm12144793","article-title":"Beard alopecia:An updated and comprehensive review of etiologies, presentation and treatment","volume":"12","author":"Kaiser","year":"2023","journal-title":"J Clin Med"},{"key":"R15-20251211","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R16-20251211","article-title":"Chapter 8:Assessing risk of bias in a randomized trial","author":"Higgins","year":"2023","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 64. Cochrane"},{"key":"R17-20251211","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00403-023-02679-2","article-title":"Comparative study of the efficacy and safety of topical minoxidil 2% in treatment of eyebrow hypotrichosis:A randomized controlled trial","volume":"315","author":"Zaky","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R18-20251211","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/jocd.14299","article-title":"SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth","volume":"21","author":"Dhurat","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R19-20251211","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female pattern hair loss:A Randomized clinical trial","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R20-20251211","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil versus 3% minoxidil solution in the treatment of male androgenetic alopecia","volume":"32","author":"Suchonwanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-20251211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546634.2017.1330527","article-title":"Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata","volume":"29","author":"El-Ashmawy","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"R22-20251211","first-page":"573","article-title":"Treatment of eyebrow hypotrichosis with 1% minoxidil lotion:A prospective, randomized, double-blind, placebo-controlled trial","volume":"100","author":"Worapunpong","year":"2017","journal-title":"J Med Assoc Thai"},{"key":"R23-20251211","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/1346-8138.13312","article-title":"Efficacy and safety of minoxidil 3% lotion for beard enhancement:A randomized, double-masked, placebo-controlled study","volume":"43","author":"Ingprasert","year":"2016","journal-title":"J Dermatol"},{"key":"R24-20251211","first-page":"883","article-title":"Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss:A Phase III, randomized, investigator-blinded study","volume":"15","author":"Blume-Peytavi","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R25-20251211","first-page":"874","article-title":"A Phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss","volume":"15","author":"Bergfeld","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R26-20251211","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000375320","article-title":"A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men","volume":"28","author":"Hillmann","year":"2015","journal-title":"Ski Pharmacol Physiol"},{"key":"R27-20251211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1346-8138.12275","article-title":"Minoxidil 2% lotion for eyebrow enhancement:A randomized, double-blind, placebo-controlled, split-face comparative study","volume":"41","author":"Lee","year":"2014","journal-title":"J Dermatol"},{"key":"R28-20251211","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1346-8138.2012.01579.x","article-title":"Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows:A randomized, double-blind, split-face comparative study","volume":"39","author":"Suwanchatchai","year":"2012","journal-title":"J Dermatol"},{"key":"R29-20251211","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R30-20251211","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R31-20251211","first-page":"37","article-title":"A randomized, placebo- controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women","volume":"17","author":"Tsuboi","year":"2007","journal-title":"Eur J Dermatol"},{"key":"R32-20251211","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R33-20251211","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2133.2003.05435.x","article-title":"Therapeutics The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density:A randomized controlled trial","volume":"149","author":"Berger","year":"2003","journal-title":"Br J Dermatol"},{"key":"R34-20251211","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R35-20251211","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/ijd.14933","article-title":"Low-dose oral minoxidil as treatment for non-scarring alopecia:A systematic review","volume":"59","author":"Sharma","year":"2020","journal-title":"Int J Dermatol"},{"key":"R36-20251211","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil:Mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"key":"R37-20251211","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R38-20251211","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2133.1997.d01-1156.x","article-title":"Diffuse hypertrichosis during treatment with 5% topical minoxidil","volume":"136","author":"Peluso","year":"1997","journal-title":"Br J Dermatol"},{"key":"R39-20251211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"R40-20251211","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2133.1999.02666.x","article-title":"The induction by topical minoxidil of increased fenestration in the perifollicular capillary wall","volume":"140","author":"Sakita","year":"1999","journal-title":"Br J Dermatol"},{"key":"R41-20251211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI11317","article-title":"Control of hair growth and follicle size by VEGF-mediated angiogenesis","volume":"107","author":"Yano","year":"2001","journal-title":"J Clin Invest"},{"key":"R42-20251211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"key":"R43-20251211","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ijms19010053","article-title":"Minoxidil induction of VEGF is mediated by inhibition of HIF-prolyl hydroxylase","volume":"19","author":"Yum","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R44-20251211","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1523-1747.ep12334249","article-title":"Activation of cytoprotective prostaglandin synthase-l by minoxidil as a possible explanation for its hair growth-stimulating effect","volume":"108","author":"Michelet","year":"1997","journal-title":"J Invest Dermatol"},{"key":"R45-20251211","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-2952(88)90174-8","article-title":"Selective inhibition by minoxidil of prostacyclin production by cells in culture","volume":"37","author":"Kvedar","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"R46-20251211","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdermsci.2010.02.011","article-title":"Identification of transcriptional targets of Wnt\/b-catenin signaling in dermal papilla cells of human scalp hair follicles:EP2 is a novel transcriptional target of Wnt3a","volume":"58","author":"Shin","year":"2010","journal-title":"J Dermatol Sci"},{"key":"R47-20251211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jocd.14525","article-title":"Microneedling for hair loss","volume":"21","author":"Gupta","year":"2022","journal-title":"J Cosmet Dermatol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_39_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:52Z","timestamp":1787068072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_39_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_39_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2025-01-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}